A Journey to the Cutting Edge of Bioscience: Cancer as a Case Study

Опубликовано: 10 Март 2020
на канале: Milken Institute

554

Today, the line between clinical practice and clinical research is becoming blurred, largely thanks to investments in data, the existence of highly networked centers of excellence, and the work of research communities. Yet there is still much more to be achieved to create an optimal environment that ensures timely diagnoses and treatments. This panel will discuss the state of cancer care. What has been achieved? What are the most pressing barriers? And what are the greatest discoveries for other diseases?

Moderator
Margaret Anderson
Managing Director, Deloitte Consulting

Speakers
Greg Friberg
Vice President, Global Development for Oncology, Amgen

Douglas Lowy
Acting Director, National Cancer Institute, National Institutes of Health

Fouad Namouni
Head of Oncology Development, Bristol-Myers Squibb

Ellen Sigal
Chairperson and Founder, Friends of Cancer Research

Nikhil Wagle
Director, Count Me In, Broad Institute